Patientswith breast cancers (n=116, P=0.025) thatexpressed higher mRNA levels of Bcl-3 had a significantly lowermetastasis-free survival than patients whose tumors expressed lower levelsof Bcl-3 (Figure 1c). Here, BCL3 is linked to breast cancer.